Ann: Althea Reaches 2329 Patients After Record Month, page-9

IMO I see a few factors influencing SP at present:

1. Recession fears for retail holders
2. Recent “black market” vape oil quality & health concerns
3. Retail Selling & claiming 50% CGT “discount” as shares have now been held for over 1 year (if bought near time of original ASX listing - Sept 21st from memory)

Personally I think Aphria (major holder) is in one of the most resilient positions in the US of all pot stocks having the short attack already smash the SP earlier this year. It has been trading at a considerable discount ever since but is well financed and earning coin - everyone else is massively over inflated and about to get shorted heavily.

IMO we’re going to bounce around a bit until retail have calmed down and we hear more positive news. Then onwards and upwards.

cheers to all long holders.

DYOR IMO